Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Influenza | Research article

A systems biology-driven approach to construct a comprehensive protein interaction network of influenza A virus with its host

Authors: Qurat ul Ain Farooq, Zeeshan Shaukat, Sara Aiman, Tong Zhou, Chunhua Li

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Influenza A virus (IAV) infection is a serious public health problem not only in South East Asia but also in European and African countries. Scientists are using network biology to dig deep into the essential host factors responsible for regulation of virus infections. Researchers can explore the virus invasion into the host cells by studying the virus-host relationship based on their protein-protein interaction network.

Methods

In this study, we present a comprehensive IAV-host protein-protein interaction network that is obtained based on the literature-curated protein interaction datasets and some important interaction databases. The network is constructed in Cytoscape and analyzed with its plugins including CytoHubba, CytoCluster, MCODE, ClusterViz and ClusterOne. In addition, Gene Ontology and KEGG enrichment analyses are performed on the highly IAV-associated human proteins. We also compare the current results with those from our previous study on Hepatitis C Virus (HCV)-host protein-protein interaction network in order to find out valuable information.

Results

We found out 1027 interactions among 829 proteins of which 14 are viral proteins and 815 belong to human proteins. The viral protein NS1 has the highest number of associations with human proteins followed by NP, PB2 and so on. Among human proteins, LNX2, MEOX2, TFCP2, PRKRA and DVL2 have the most interactions with viral proteins. Based on KEGG pathway enrichment analysis of the highly IAV-associated human proteins, we found out that they are enriched in the KEGG pathway of basal cell carcinoma. Similarly, the result of KEGG analysis of the common host factors involved in IAV and HCV infections shows that these factors are enriched in the infection pathways of Hepatitis B Virus (HBV), Viral Carcinoma, measles and certain other viruses.

Conclusion

It is concluded that the list of proteins we identified might be used as potential drug targets for the drug design against the infectious diseases caused by Influenza A Virus and other viruses.
Appendix
Available only for authorised users
Literature
1.
Gutiérrez RA, Naughtin MJ, Horm SV, San S, Buchy P. A(H5N1) virus evolution in South East Asia. Viruses. 2009;1(3):335–61.PubMedPubMedCentral
2.
Claas ECJ, Osterhaus ADME, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG. Human influenza a H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 1998;351(9101):472–7.PubMed
3.
Hu Y, Sneyd H, Dekant R, Wang J. Influenza a virus nucleoprotein: a highly conserved multi-functional viral protein as a hot antiviral drug target. Curr Top Med Chem. 2017;17(20):2271–85.PubMedPubMedCentral
4.
Vasin AV, Temkina OA, Egorov VV, Klotchenko SA, Plotnikova MA, Kiselev OI. Molecular mechanisms enhancing the proteome of influenza a viruses: an overview of recently discovered proteins. Virus Res. 2014;185:53–63.PubMed
5.
Tscherne DM, García-Sastre A. Virulence determinants of pandemic influenza viruses. J Clin Invest. 2011;121(1):6–13.PubMedPubMedCentral
6.
Zhao M, Wang L, Li S. Influenza a virus-host protein interactions control viral pathogenesis. Int J Mol Sci. 2017;18(8):1673.PubMedCentral
7.
8.
Kamal RP, Alymova IV, York IA. Evolution and virulence of influenza a virus protein PB1-F2. Int J Mol Sci. 2017;19(1):96.PubMedCentral
9.
10.
11.
Subramani C, Nair VP, Anang S, Mandal SD, Pareek M, Kaushik N, Srivastava A, Saha S, Shalimar NB, et al. Host-Virus protein interaction network reveals the involvement of multiple host processes in the life cycle of hepatitis E virus. mSystems. 2018;3(1):e00135–17.PubMedPubMedCentral
12.
Pereira CF, Wise HM, Kurian D, Pinto RM, Amorim MJ, Gill AC, Digard P. Effects of mutations in the effector domain of influenza a virus NS1 protein. BMC Res Notes. 2018;11(1):673.PubMedPubMedCentral
13.
García-Pérez CA, Guo X, Navarro JG, Aguilar DAG, Lara-Ramírez EE. Proteome-wide analysis of human motif-domain interactions mapped on influenza a virus. BMC Bioinformatics. 2018;19(1):238.PubMedPubMedCentral
14.
Kordyukova LV, Shtykova EV, Baratova LA, Svergun DI, Batishchev OV. Matrix proteins of enveloped viruses: a case study of influenza a virus M1 protein. J Biomol Struct Dyn. 2019;37(3):671–90.PubMed
15.
Mok BW-Y, Liu H, Chen P, Liu S, Lau S-Y, Huang X, Liu Y-C, Wang P, Yuen K-Y, Chen H. The role of nuclear NS1 protein in highly pathogenic H5N1 influenza viruses. Microbes Infect. 2017;19(12):587–96.PubMed
16.
Wang BX, Fish EN. Interactions between NS1 of influenza a viruses and interferon-α/β: determinants for vaccine development. J Interf Cytokine Res. 2017;37(8):331–41.
17.
Kuo R-L, Li Z-H, Li L-H, Lee K-M, Tam E-H, Liu HM, Liu H-P, Shih S-R, Wu C-C. Interactome analysis of the NS1 protein encoded by influenza a H1N1 virus reveals a positive regulatory role of host protein PRP19 in viral replication. J Proteome Res. 2016;15(5):1639–48.PubMed
18.
Sun N, Sun W, Li S, Yang J, Yang L, Quan G, Gao X, Wang Z, Cheng X, Li Z, et al. Proteomics analysis of cellular proteins co-immunoprecipitated with nucleoprotein of influenza a virus (H7N9). Int J Mol Sci. 2015;16(11):25982–98.PubMedPubMedCentral
19.
Cheong W-C, Kang H-R, Yoon H, Kang S-J, Ting JPY, Song MJ. Influenza a virus NS1 protein inhibits the NLRP3 Inflammasome. PLoS One. 2015;10(5):e0126456.PubMedCentral
20.
Gao S, Wu J, Liu R-Y, Li J, Song L, Teng Y, Sheng C, Liu D, Yao C, Chen H, et al. Interaction of NS2 with AIMP2 facilitates the switch from Ubiquitination to SUMOylation of M1 in influenza a virus-infected cells. J Virol. 2015;89(1):300.PubMed
21.
York A, Hutchinson EC, Fodor E. Interactome analysis of the influenza a virus transcription/replication machinery identifies protein phosphatase 6 as a cellular factor required for efficient virus replication. J Virol. 2014;88(22):13284.PubMedPubMedCentral
22.
Engel DA. The influenza virus NS1 protein as a therapeutic target. Antivir Res. 2013;99(3):409–16.PubMed
23.
Tripathi S, Batra J, Cao W, Sharma K, Patel JR, Ranjan P, Kumar A, Katz JM, Cox NJ, Lal RB, et al. Influenza a virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin. Cell Death Dis. 2013;4(3):e562.PubMedPubMedCentral
24.
Fournier E, Moules V, Essere B, Paillart J-C, Sirbat J-D, Cavalier A, Rolland J-P, Thomas D, Lina B, Isel C, et al. Interaction network linking the human H3N2 influenza a virus genomic RNA segments. Vaccine. 2012;30(51):7359–67.PubMed
25.
Guan ZH, Zhang ML, Hou PL, Duan M, Cui YM, Wang XR. Identification of cellular proteins interacting with influenza a virus PB1-F2 protein. Acta Virol. 2012;56(3):199–207.PubMed
26.
Mok BW-Y, Song W, Wang P, Tai H, Chen Y, Zheng M, Wen X, Lau S-Y, Wu WL, Matsumoto K, et al. The NS1 protein of influenza a virus interacts with cellular processing bodies and stress granules through RNA-associated protein 55 (RAP55) during virus infection. J Virol. 2012;86(23):12695–707.PubMedPubMedCentral
27.
Demirov D, Gabriel G, Schneider C, Hohenberg H, Ludwig S. Interaction of influenza a virus matrix protein with RACK1 is required for virus release. Cell Microbiol. 2012;14(5):774–89.PubMed
28.
Yan Q. Systems Biology of Influenza: Understanding Multidimensional Interactions for Personalized Prevention and Treatment. In: Yan Q, editor. Systems Biology in Drug Discovery and Development: Methods and Protocols. Totowa, NJ: Humana Press; 2010. p. 285–302.
29.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.PubMedPubMedCentral
30.
Assenov Y, Ramírez F, Schelhorn S-E, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2007;24(2):282–4.PubMed
31.
Su G, Morris JH, Demchak B, Bader GD. Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics. 2014;47:8.13.11–18.13.24.
32.
Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.PubMedPubMedCentral
33.
Li M, Li D, Tang Y, Wu F, Wang J. CytoCluster: a Cytoscape plugin for cluster analysis and visualization of biological networks. Int J Mol Sci. 2017;18(9):1880.PubMedCentral
34.
Pundir S, Martin MJ, O'Donovan C, UniProt C. UniProt tools. Curr Protoc Bioinformatics. 2016;53:1.29.21–21.29.15.
35.
Mohamed S, Janus N, Qi Y. SCODE: A Cytoscape app for supervised complex detection in protein-protein interaction graphs. F1000Research. 2016;5:1699.
36.
Nepusz T, Yu H, Paccanaro A. Detecting overlapping protein complexes in protein-protein interaction networks. Nat Methods. 2012;9(5):471–2.PubMedPubMedCentral
37.
Wang J, Zhong J, Chen G, Li M, Wu F-X, Pan Y. ClusterViz: a Cytoscape APP for cluster analysis of biological network. IEEE/ACM Trans Comput Biol Bioinform. 2015;12:815–22.PubMed
38.
Morris JH, Apeltsin L, Newman AM, Baumbach J, Wittkop T, Su G, Bader GD, Ferrin TE. clusterMaker: a multi-algorithm clustering plugin for Cytoscape. BMC Bioinformatics. 2011;12(1):436.PubMedPubMedCentral
39.
Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2016;45(D1):D353–61.PubMedPubMedCentral
40.
Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90–7.PubMedPubMedCentral
41.
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. the gene ontology consortium. Nat Genet. 2000;25(1):25–9.PubMedPubMedCentral
42.
Li Z, Qiao Z, Zheng W, Ma W. Network cluster analysis of protein-protein interaction network-identified biomarker for type 2 diabetes. Diabetes Technol Ther. 2015;17(7):475–81.PubMedPubMedCentral
43.
Liu C, Liu L, Zhou C, Zhuang J, Wang L, Sun Y, Sun C. Protein–protein interaction networks and different clustering analysis in Burkitt’s lymphoma. Hematology. 2018;23(7):391–8.PubMed
44.
Farooq QA, Khan FF. Construction and analysis of a comprehensive protein interaction network of HCV with its host Homo sapiens. BMC Infect Dis. 2019;19(1):367.PubMedPubMedCentral
45.
Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, et al. Human infection with a novel avian-origin influenza a (H7N9) virus. N Engl J Med. 2013;368(20):1888–97.PubMed
46.
47.
Shen Z, Lou K, Wang W. New small-molecule drug design strategies for fighting resistant influenza a. Acta Pharm Sin B. 2015;5(5):419–30.PubMedPubMedCentral
48.
Christopher FB. Influenza viruses: basic biology and potential drug targets. Infect Disord Drug Targets. 2007;7(4):282–93.
49.
Watanabe T, Kawaoka Y. Influenza virus-host interactomes as a basis for antiviral drug development. Curr Opin Virol. 2015;14:71–8.PubMedPubMedCentral
50.
Li Q, Lai L. Prediction of potential drug targets based on simple sequence properties. BMC Bioinformatics. 2007;8(1):353.PubMedPubMedCentral
51.
Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol. 2011;162(6):1239–49.PubMedPubMedCentral
Metadata
Title
A systems biology-driven approach to construct a comprehensive protein interaction network of influenza A virus with its host
Authors
Qurat ul Ain Farooq
Zeeshan Shaukat
Sara Aiman
Tong Zhou
Chunhua Li
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05214-0

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue

Research article

Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial

Research article

Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: retrospective follow-up study

Research article

Long-term immunological responses to treatment among HIV-2 patients in Côte d’Ivoire

Research article

Statistical methods for predicting tuberculosis incidence based on data from Guangxi, China

Study protocol

Prospective, observational study to assess the performance of CAA measurement as a diagnostic tool for the detection of Schistosoma haematobium infections in pregnant women and their child in Lambaréné, Gabon: study protocol of the freeBILy clinical trial in Gabon

Debate

Diagnosing congenital Cytomegalovirus infection: don’t get rid of dried blood spots
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits